Status:
COMPLETED
Long-Term Dopamine Transporter Imaging and Clinical Assessment of Parkinson's Disease Progression
Lead Sponsor:
Institute for Neurodegenerative Disorders
Collaborating Sponsors:
United States Department of Defense
Conditions:
Parkinson Disease
Eligibility:
All Genders
22+ years
Phase:
PHASE2
Brief Summary
The purpose of this project is to assess the change in dopamine transporter density in Parkinson's disease subjects during a sixty month period including a nine month treatment trial of levodopa. Dopa...
Detailed Description
All subjects will be imaged at the Institute for Neurodegenerative Disorders. Subjects will be evaluated sequentially with \[123I\]ß-CIT SPECT and standardized clinical rating scales during a sixty m...
Eligibility Criteria
Inclusion
- Prior participation in the study titled Dopamine Transporter Imaging Assessment of Parkinson's Disease Progression (DAMD17-99-1-9472) \[123I\] B-CIT and Spect in Vivo Imaging Assessment of Dopamine Transporter Density in Subjects With Early Parkinson's Disease Participating in Earlier Vs. Later Levodopa in Parkinson's Disease (ELLDOPA)\].
Exclusion
- Inability to sign informed consent and participate in all study procedures.
- Mini mental status exam \< 25.
- Pregnancy
Key Trial Info
Start Date :
April 1 2000
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2007
Estimated Enrollment :
142 Patients enrolled
Trial Details
Trial ID
NCT00134784
Start Date
April 1 2000
End Date
May 1 2007
Last Update
August 8 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.